Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy
Clinical trial NCT03700723 · TERMINATED
Trial details
- NCT number
- NCT03700723
- Sponsor
- Entegrion, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2020-04-15
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.